Biomarker analysis reveals clues to long-term survival in glioblastoma patients treated with SurVaxM
by Roswell Park Comprehensive Cancer Center edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes Landscape of genetic alterations in GBM tumors prior to treatment. Credit: Cancer Immunology, Immunotherapy (2025). DOI: 10.1007/s00262-025-04193-y Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others […]
